Health

Topical Olive Oil Prevents Pressure Ulcers in Immobilized Patients

Topical application of extra virgin olive oil is a more cost effective alternative for preventing pressure ulcers in immobilized patients with the same beneficial outcomes as commonly used skin care products.

Mar. 30, 2016
By Jedha Dening

Recent News

Pres­sure ulcers are a com­mon skin issue that causes health­care, eco­nomic, and social bur­dens. The ulcers can appear any­where on the body, but because they are more com­mon in immo­bi­lized patients, par­tic­u­larly the elderly, they are more fre­quently seen on the sacrum, hips and heels.

A pres­sure ulcer is a skin lesion, a wound that is pro­duced sec­ondary to inad­e­quate blood sup­ply to the area. The pres­sure accu­mu­lates when the soft tis­sue is com­pressed between two planes — for exam­ple, the hos­pi­tal bed, the soft tis­sue, and the weight of the patient’s hip bone. The ulcers can lead to necro­sis (death of body tis­sue) and there­fore can also affect the joints, bones, and greatly impact qual­ity of life.

Strate­gies to pre­vent pres­sure ulcers include the assess­ment of risk fac­tors, the use of sup­port sur­faces, repo­si­tion­ing the patient, main­tain­ing opti­mal nutri­tional sta­tus, hydra­tion and skin care. The phar­ma­ceu­ti­cal indus­try has launched skin care prod­ucts that con­tain oils derived from hyper­ox­y­genated fatty acids (HOFA) to treat pres­sure ulcers.

Although there are stud­ies show­ing the effec­tive­ness of HOFA skin care prod­ucts, there is a high cost, par­tic­u­larly when ongo­ing treat­ment is required. In a study, pub­lished in PLOS ONE, Lupiañez-Perez and Col­leagues sort to deter­mine whether the use of olive oil could achieve sim­i­lar ben­e­fi­cial out­comes for immo­bi­lized patients.

The authors report that, Olive oil has between 330 to 500 mg of polyphe­nolsperk­ilo­gram of fat, and under 20mEq of per­ox­ide perk­ilo­gram of fat. It is com­pat­i­ble with human tis­sues what con­verts it in an ideal prod­uct for topic use.” Not to men­tion, oleic acid, nat­ural antiox­i­dants such as hydrox­y­ty­rosol and tyrosol and high resis­tance to oxida­tive processes, all of which inspired the hypoth­e­sis that olive oil could be a more cost-effec­tive treat­ment for pres­sure ulcers with sim­i­lar ben­e­fits to HOFA skin care prod­ucts.

Accord­ing to the authors, the sub­jects selected for the 16-week fol­low-up trial were sim­i­lar to the sub­jects exam­ined in HOFA effi­cacy tri­als.” In the 16 week fol­low up trial, the inci­dence of stage 2 pres­sure ulcers was mea­sured as the main out­come in 915 patients (aver­age age of patients 80.56 years) who were ran­dom­ized to either, HOFA appli­ca­tion or two appli­ca­tions daily of the olive- oil-based for­mula, to the skin areas of the sacrum, hips and heels” in the form of 0.33 ml in each spray­ing. The liq­uid spray con­tained 97 per­cent extra vir­gin olive oil and 3 per­cent hyper­icum per­fo­ra­tum and pep­per­mint.

The authors con­clude that the results obtained con­firm the non-infe­ri­or­ity of the olive oil treat­ment; there were no dif­fer­ences exceed­ing the lower limit of the con­fi­dence inter­val and thus olive oil ther­apy achieves an effec­tive pre­ven­tion of pres­sure ulcers in these cir­cum­stances.”

For exam­ple, the spe­cific val­ues for the sacrum with 8 sub­jects in either group were 2.55 per­cent for olive oil and 3.08 per­cent for HOFA. It is also impor­tant to note that pre­vi­ous stud­ies on HOFA have never been con­ducted beyond one month. There­fore, the length of this study pro­vides clin­i­cal sig­nif­i­cance for the effec­tive­ness of olive oil as a top­i­cal agent.

As the authors sug­gest, The lower cost of the prod­uct makes it more acces­si­ble to the pop­u­la­tion in gen­eral and to the health­care sys­tem, and offers a viable alter­na­tive to stan­dard HOFA treat­ment promis­ing a sig­nif­i­cant reduc­tion in phar­ma­ceu­ti­cal expen­di­ture and alle­vi­at­ing the bur­dens placed on health care per­son­nel and care­givers, by reduc­ing the inci­dence of pres­sure ulcers.”


Related News